Home / Escitalopram / Italy
IT ATC N06AB10 · updated 2 Nov 2026
Escitalopram shortage in Italy
Is there an Escitalopram shortage in Italy?
Yes. As of 2 Nov 2026, 9 Escitalopram products are reported short in Italy, the first since 30 Dec 2022. The company estimate for the return is 31 Mar 2027 (latest 30 Jun 2027). Main reason: manufacturing problem.
Also short in Canada, Germany, Spain, Ireland, Austria, Belgium, Czechia, Norway, Sweden. All countries.
Affected products in Italy
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | ESCITALOPRAM ZENTIVA | ZENTIVA ITALIA S.R.L. | 30 Dec 2022 | not given | Manufacturing problem Problemi produttivi: forniture discontinue |
| IT | ESCITALOPRAM SUN | SUN PHARMACEUTICAL INDUSTRIES (EUROPE) B.V. | 15 Dec 2023 | not given | Manufacturing problem Problemi produttivi |
| IT | ESCITALOPRAM ZENTIVA | ZENTIVA ITALIA S.R.L. | 15 Dec 2023 | not given | Manufacturing problem Problemi produttivi |
| IT | ESCITALOPRAM MYLAN | MYLAN S.P.A. | 10 Dec 2025 | not given | Manufacturing problem Problemi produttivi |
| IT | ESCITALOPRAM PENSA | TOWA PHARMACEUTICAL S.P.A. | 13 Apr 2026 | 31 Mar 2027 | Manufacturing problem Problemi produttivi |
| IT | ESCITALOPRAM ACCORD | ACCORD HEALTHCARE, S.L.U. | 24 Apr 2026 | not given | Increased demand Elevata richiesta |
| IT | ESCITALOPRAM ACCORD | ACCORD HEALTHCARE, S.L.U. | 24 Apr 2026 | not given | Increased demand Elevata richiesta |
| IT | ESCITALOPRAM EG STADA | EG S.P.A. | 1 Jun 2026 | not given | Regulatory or licensing Problemi regolatori |
| IT | ESCITALOPRAM PENSA | TOWA PHARMACEUTICAL S.P.A. | 1 Oct 2026 | 30 Jun 2027 | Regulatory or licensing Problemi regolatori |
Source
AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.